Genevia Lifesciences Ltd – Trademark Portfolio

Entity Type: 99

Genevia Lifesciences Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GOBI GOLD.

71-75 Shelton Street,

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

0123
0123
Abandoned 2020
GOBI GOLD
GOBI GOLD
Registered 2019

Trademark Classifications

Genevia Lifesciences Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Genevia Lifesciences Ltd have?

Genevia Lifesciences Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Genevia Lifesciences Ltd file in?

Genevia Lifesciences Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Genevia Lifesciences Ltd's most well-known trademarks?

Genevia Lifesciences Ltd's registered trademark portfolio includes well-known marks such as GOBI GOLD. These are among 1 currently registered trademark in the portfolio.

What is Genevia Lifesciences Ltd's trademark registration success rate?

Genevia Lifesciences Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.